Chiranthi Welhenge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chiranthi Welhenge has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Anuradhani Kasturiratne
Affiliation Department of Public Health, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
3 shared publications - Kavindya Fernando
Department of Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
3 shared publications - Nilshan Fernando
University Medical Unit, Colombo North Teaching Hospital, Ragama, Sri Lanka
3 shared publications Anuja Premawardhena
Department of Medicine, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
2 shared publications- Arjuna Priyadarshin De Silva
Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
2 shared publications Dilakshi Lekamge
Faculty of Medicine, University of Kelaniya
2 shared publications
Latest Publications
- Open Access
- 16 April 2026
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 19 (1) , 109
Application of HEART, GRACE 2.0 and TIMI scores for risk stratification of chest pain: a single-centre external pilot study in a Sri Lankan population
HEART score is widely used for risk stratification in patients with chest pain. TIMI and GRACE 2.0 scores are recommended for prognostication in patients w
- 16 April 2026
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 19 (1) , 109
Open AccessApplication of HEART, GRACE 2.0 and TIMI scores for risk stratification of chest pain: a single-centre external pilot study in a Sri Lankan population
HEART score is widely used for risk stratification in patients with chest pain. TIMI and GRACE 2.0 scores are recommended for prognostication in patients w
- Open Access
Evaluation of HEART score, GRACE 2.0 score, and TIMI score for Risk Stratification in Acute Coronary Syndrome: A Single-Centre Pilot Study in a Sri Lankan Population
Objectives: HEART score is widely used for risk stratification, in patients with chest pain, to rule out acute coronary syndrome (ACS). Although limited, it has been validated in several countries throughout the world. TIMI and GRACE 2.0 scores are recommended for prognostication in patients with ACS. This study aimed to explore the effectiveness of HEART score, in a Sri Lankan population, for risk stratification, in patients presenting with chest pain and to compare its performance with GRACE 2.0 and TIMI scores. Methods: Data was collected from 74 patients presenting to the emergency department at a tertiary care centre in Sri Lanka. HEART, GRACE 2.0 and TIMI scores were calculated for each patient separately. The predictive accuracy of the HEART score with a diagnosis of ACS and the occurrence of major adverse cardiac events (MACE) at 6 weeks was assessed and compared with TIMI and GRACE 2.0. scores. Results: Area under receiver operating curve (AUC-ROC) for HEART, GRACE 2.0 and TIMI, for a diagnosis of ACS, were 0.889 (95% CI: 0.8171 - 0.9609), 0.805 (95% CI: 0.6758 - 0.9349), 0.812 (95% CI: 0.6961 - 0.9278) respectively. Delong’s test did not indicate a significant pairwise difference in scores. AUC-ROC for occurrence of MACE were 0.905 (95% CI: 0.8437 - 0.9669), 0.721 (95% CI: 0.5934 – 0.8493) and 0.767 (95% CI: 0.6467 – 0.888), for HEART, GRACE 2.0 and TIMI scores respectively, and these differences were statistically significant. Conclusions: HEART score is an effective score which can be used in Sri Lankans, in predicting the probability of ACS, and MACE within 6 weeks, in patients presenting with chest pain. It is comparable to GRACE 2.0 and TIMI scores in diagnostic accuracy while it is superior to GRACE and TIMI scores in predictive accuracy for short term risk of MACE.
Open AccessEvaluation of HEART score, GRACE 2.0 score, and TIMI score for Risk Stratification in Acute Coronary Syndrome: A Single-Centre Pilot Study in a Sri Lankan Population
Objectives: HEART score is widely used for risk stratification, in patients with chest pain, to rule out acute coronary syndrome (ACS). Although limited, it has been validated in several countries throughout the world. TIMI and GRACE 2.0 scores are recommended for prognostication in patients with ACS. This study aimed to explore the effectiveness of HEART score, in a Sri Lankan population, for risk stratification, in patients presenting with chest pain and to compare its performance with GRACE 2.0 and TIMI scores. Methods: Data was collected from 74 patients presenting to the emergency department at a tertiary care centre in Sri Lanka. HEART, GRACE 2.0 and TIMI scores were calculated for each patient separately. The predictive accuracy of the HEART score with a diagnosis of ACS and the occurrence of major adverse cardiac events (MACE) at 6 weeks was assessed and compared with TIMI and GRACE 2.0. scores. Results: Area under receiver operating curve (AUC-ROC) for HEART, GRACE 2.0 and TIMI, for a diagnosis of ACS, were 0.889 (95% CI: 0.8171 - 0.9609), 0.805 (95% CI: 0.6758 - 0.9349), 0.812 (95% CI: 0.6961 - 0.9278) respectively. Delong’s test did not indicate a significant pairwise difference in scores. AUC-ROC for occurrence of MACE were 0.905 (95% CI: 0.8437 - 0.9669), 0.721 (95% CI: 0.5934 – 0.8493) and 0.767 (95% CI: 0.6467 – 0.888), for HEART, GRACE 2.0 and TIMI scores respectively, and these differences were statistically significant. Conclusions: HEART score is an effective score which can be used in Sri Lankans, in predicting the probability of ACS, and MACE within 6 weeks, in patients presenting with chest pain. It is comparable to GRACE 2.0 and TIMI scores in diagnostic accuracy while it is superior to GRACE and TIMI scores in predictive accuracy for short term risk of MACE.
- Open Access
Validity of the “HEART” Score as an Early Assessment Tool in Acute Coronary Syndrome in a Sri Lankan Population: A Single Centre Pilot Study
Objectives: The HEART score is a clinical tool used for early risk stratification in patients presenting with chest pain in emergency settings, which facilitates prognostication. Although limited, it has been validated in several countries throughout the world. This study aimed to assess the validity of HEART score, in a Sri Lankan population, as an early assessment tool, for risk prediction of acute coronary syndrome (ACS), in patients presenting with chest pain. Methods: Data was collected from 74 patients presenting to the emergency department at a tertiary care centre in Sri Lanka. HEART score was calculated for each patient retrospectively and patients were categorized into low (0-3), intermediate (4-6), and high (7-10) risk groups. The predictive accuracy of the HEART score with a diagnosis of ACS and the occurrence of major adverse cardiac events (MACE) at 6 weeks was assessed. Statistical analysis was performed using R studio. Results: All patients in the low-risk group (n=8) were correctly identified as non-ACS, with no MACE. All high-risk patients (n=29) had ACS and experienced MACE. Among the intermediate risk group (n=37), 70.3% were diagnosed with ACS and 54% developed MACE at 6 weeks. Area under curve (AUC) for HEART score for a diagnosis of ACS, was 0.889 (95% CI: 0.8171-0.9609) while the AUC for occurrence of MACE was 0.9053 (95% CI: 0.8437 - 0.9669). Conclusions: The HEART score is an effective early assessment tool which can be used in Sri Lankans, in prediction of the probability of ACS, and MACE within 6 weeks, in patients presenting with chest pain.
Open AccessValidity of the “HEART” Score as an Early Assessment Tool in Acute Coronary Syndrome in a Sri Lankan Population: A Single Centre Pilot Study
Objectives: The HEART score is a clinical tool used for early risk stratification in patients presenting with chest pain in emergency settings, which facilitates prognostication. Although limited, it has been validated in several countries throughout the world. This study aimed to assess the validity of HEART score, in a Sri Lankan population, as an early assessment tool, for risk prediction of acute coronary syndrome (ACS), in patients presenting with chest pain. Methods: Data was collected from 74 patients presenting to the emergency department at a tertiary care centre in Sri Lanka. HEART score was calculated for each patient retrospectively and patients were categorized into low (0-3), intermediate (4-6), and high (7-10) risk groups. The predictive accuracy of the HEART score with a diagnosis of ACS and the occurrence of major adverse cardiac events (MACE) at 6 weeks was assessed. Statistical analysis was performed using R studio. Results: All patients in the low-risk group (n=8) were correctly identified as non-ACS, with no MACE. All high-risk patients (n=29) had ACS and experienced MACE. Among the intermediate risk group (n=37), 70.3% were diagnosed with ACS and 54% developed MACE at 6 weeks. Area under curve (AUC) for HEART score for a diagnosis of ACS, was 0.889 (95% CI: 0.8171-0.9609) while the AUC for occurrence of MACE was 0.9053 (95% CI: 0.8437 - 0.9669). Conclusions: The HEART score is an effective early assessment tool which can be used in Sri Lankans, in prediction of the probability of ACS, and MACE within 6 weeks, in patients presenting with chest pain.
- Open Access
- 18 July 2024
- Published by Sri Lanka Journals Online in Journal of the Ceylon College of Physicians
- Vol. 55 (1) , 41-43
Patients’ right to confidentiality and sharing information with colleagues: The dilemma in managing a patient with Munchausen syndrome – A case report
We report the case of a young woman with a “pyrexia of unknown origin” in the background of a history involving SLE, ocular toxoplasmosis and Ig A nephropathy. The history was narrated by her with precise details but there was no documentary proof of any previous admissions. She had a prolonged hospital stay and repeated hospital admissions for the same illness with extensive investigations including a PET scan. Once evidence for “factitious fever” was overwhelming she got herself discharged from hospital refusing psychiatric help. Close scrutiny revealed that she had got herself admitted to several hospitals in the Western Province subsequently, with the same complaint, with all clinicians investigating her extensively, sometimes including invasive procedures. The ethical dilemma faced by us relating to sharing her clinical details with a wider clinical group is discussed.
- 18 July 2024
- Published by Sri Lanka Journals Online in Journal of the Ceylon College of Physicians
- Vol. 55 (1) , 41-43
Open AccessPatients’ right to confidentiality and sharing information with colleagues: The dilemma in managing a patient with Munchausen syndrome – A case report
We report the case of a young woman with a “pyrexia of unknown origin” in the background of a history involving SLE, ocular toxoplasmosis and Ig A nephropathy. The history was narrated by her with precise details but there was no documentary proof of any previous admissions. She had a prolonged hospital stay and repeated hospital admissions for the same illness with extensive investigations including a PET scan. Once evidence for “factitious fever” was overwhelming she got herself discharged from hospital refusing psychiatric help. Close scrutiny revealed that she had got herself admitted to several hospitals in the Western Province subsequently, with the same complaint, with all clinicians investigating her extensively, sometimes including invasive procedures. The ethical dilemma faced by us relating to sharing her clinical details with a wider clinical group is discussed.
- Open Access
- 31 October 2023
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 23 (1) , 1-5
Extensive systemic thrombo-embolism including intra-cardiac thrombosis mimicking an atrial myxoma in a patient with beta thalassaemia major – a case report
Background: Sepsis and thrombo-embolic disease are well known complications of thalassemia major. Intracardiac thrombi are however rare and can lead to diagnostic dilemmas. Case presentation: We report the case of a 20-year-old female splenectomised thalassaemia major patient with severe iron overload, who presented with life threatening sepsis associated with a liver abscess. Discovery of a large oscillating intra cardiac lesion on 2D echocardiogram confirmed by Contrast Enhanced Computed Tomography (CECT) chest in the right atrium extending from the left hepatic vein through the inferior vena cava complicated the clinical course. After a prolonged Intensive Care Unit (ICU) stay supported with antibiotics and anticoagulation, she recovered with evidence of resolution of the intra cardiac thrombus. Conclusions: Early recognition and prompt aggressive treatment of sepsis in patients with thalassemia is essential to prevent complications. Intracardiac thrombosis is a potentially treatable cause for an intra cardiac mass in patients with thalassemia major, which should not be missed.
- 31 October 2023
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 23 (1) , 1-5
Open AccessExtensive systemic thrombo-embolism including intra-cardiac thrombosis mimicking an atrial myxoma in a patient with beta thalassaemia major – a case report
Background: Sepsis and thrombo-embolic disease are well known complications of thalassemia major. Intracardiac thrombi are however rare and can lead to diagnostic dilemmas. Case presentation: We report the case of a 20-year-old female splenectomised thalassaemia major patient with severe iron overload, who presented with life threatening sepsis associated with a liver abscess. Discovery of a large oscillating intra cardiac lesion on 2D echocardiogram confirmed by Contrast Enhanced Computed Tomography (CECT) chest in the right atrium extending from the left hepatic vein through the inferior vena cava complicated the clinical course. After a prolonged Intensive Care Unit (ICU) stay supported with antibiotics and anticoagulation, she recovered with evidence of resolution of the intra cardiac thrombus. Conclusions: Early recognition and prompt aggressive treatment of sepsis in patients with thalassemia is essential to prevent complications. Intracardiac thrombosis is a potentially treatable cause for an intra cardiac mass in patients with thalassemia major, which should not be missed.
- Open Access
- 13 January 2023
- Published by Springer Nature in Research Square
Extensive systemic thrombo embolism including intra-cardiac thrombosis mimicking an atrial myxoma in a patient with beta thalassaemia major
We report the case of a 20-year-old female splenectomised thalassaemia major patient with severe iron overload, who presented with life threatening sepsis associated with a liver abscess. Her clinical course was complicated with an intra cardiac thrombus. 2D echocardiogram and Contrast Enhanced Computed Tomography (CECT) chest revealed a large oscillating mass in right atrium extending from the left hepatic vein through the inferior vena cava. After a prolonged Intensive Care Unit (ICU) stay supported with antibiotics and anticoagulation she had a good clinical recovery with evidence of resolution of the intra cardiac thrombus.
- 13 January 2023
- Published by Springer Nature in Research Square
Open AccessExtensive systemic thrombo embolism including intra-cardiac thrombosis mimicking an atrial myxoma in a patient with beta thalassaemia major
We report the case of a 20-year-old female splenectomised thalassaemia major patient with severe iron overload, who presented with life threatening sepsis associated with a liver abscess. Her clinical course was complicated with an intra cardiac thrombus. 2D echocardiogram and Contrast Enhanced Computed Tomography (CECT) chest revealed a large oscillating mass in right atrium extending from the left hepatic vein through the inferior vena cava. After a prolonged Intensive Care Unit (ICU) stay supported with antibiotics and anticoagulation she had a good clinical recovery with evidence of resolution of the intra cardiac thrombus.